CHANCELLOR’S INNOVATION CIRCLE MEMBERSHIP

RYE BARCOTT Founder, Carolina For Kibera

Charlotte, North Carolina

While an undergraduate on an NROTC scholarship at UNC in 2001, Barcott founded Carolina For Kibera (CFK) with the late nurse Tabitha Atieno Festo and community organizer Salim Mohamed. CFK fights abject poverty and prevents ethnic, gender, and religious violence through a unique model of participatory development in the Kibera slum of Nairobi, Kenya. A major affiliate of UNC based at the Center For Global Initiatives, CFK is a Time Magazine and Gates Foundation “Hero of Global Health.”

Barcott served five years on active duty in the Marine Corps before earning a combined MBA and MPA at Harvard as a Reynolds Social Entrepreneurship Fellow. He is a TED Fellow and is currently writing a book that juxtaposes humanitarian and military service (under contract, Bloomsbury Publishing).

HARRIS SCOTT BARTON Managing Director, Capital Dynamics

Palo Alto, California

Harris Barton is a Managing Director for Capital Dynamics’ Business Development team and is responsible for maintaining and fostering relationships with key clients. Harris co-founded HRJ Capital in 1999. He became a public equity and private equity investor during his football career, most notably with Sequoia Capital in the venture capital arena, beginning with Sequoia Capital VII in the early 90's. The relationships he developed in that process have been instrumental in building the network of top-tier fund managers throughout the financial

services industry available to HRJ Capital. He is a graduate of the University of North Carolina, where he received a Bachelor's Degree in Finance.

VAUGHN BRYSON President, CEO Eli Lilly & Co. (Retired)

President, Clinical Products, Ltd. Vero Beach, Florida

Vaughn D. Bryson was President and Chief Executive Officer of Eli Lilly and Company from 1991 until 1993; he was employed by Lilly for 32 years. He served as a member of the Lilly Board of Directors from 1984 until he retired in 1993. From April 1994 to December 1 996, Mr. Bryson was Vice Chairman of Vector Securities International, Inc., a private health care focused investment banking firm.

Mr. Bryson is a member of the Board of Directors of Elan Corporation, and National Wine & Spirits. He has been a board member of 16 public companies, mostly in the biotech and medical device industries. He received a B.S. degree in Pharmacy from the University of North Carolina and completed the Stanford Sloan Program at the Stanford University Graduate School of Business.

BEN CAMERON Program Director for the Arts

Doris Duke Charitable Foundation New York, New York

In 2006, Ben Cameron assumed his current position as Program Director, Arts at the Doris Duke Charitable Foundation in New York, NY. In that capacity, he supervises a $17 million grants program focusing on organizations and artists in the theatre, contemporary dance, jazz and presenting fields. Previously, he served for more than 8 years as the Executive Director of Theatre Communications Group (TCG), the national service organization for the American nonprofit

professional theater, significantly expanding its programs, membership base and grantmaking activities. Prior roles include his work as Senior Program Officer at the Dayton Hudson Foundation, Manager of Community Relations for Target Stores (supervising its grantmaking program) and four years at the National Endowment for the Arts, including two as Director of the Theater Program. A former theatre professional, frequent public speaker and arts activist, Mr. Cameron has served on numerous nonprofit boards and currently is a member of the national Grantmakers in the Arts board. He has received honorary degrees from DePaul University in Chicago and American Conservatory Theatre in San Francisco, in addition to an MFA from the Yale School of Drama. In 2007, he was one of five recipients of the Distinguished Alumnus Award from UNC. In addition to his not for profit work, he has lectured on theatre aboard the Queen Mary 2 as an Oxford Lecturer on three separate cruises, has spent 12 seasons as a panelist on the opera quiz feature on the Live from the Metropolitan broadcasts from New York, has twice ridden his bicycle from Minneapolis to Chicago to raise money for AIDS relief services, and served for three years as a member of the Tony Awards Nominating Committee.

W. LOWRY CAUDILL

Co-founder, Magellan Laboratories, Inc. (Retired) Durham, North Carolina

Chair, Innovation Circle

Dr. Lowry Caudill is the retired, worldwide President of Pharmaceutical Development for Cardinal Health. The Pharmaceutical Development business unit provided complete development services for the pharmaceutical industry. Dr. Caudill led over 1400 employees in nine sites including RTP, San Diego, Somerset NJ, Philadelphia, Manchester UK and Schorndorf GER. In April 2002, Cardinal Health acquired Magellan Laboratories Incorporated, a pharmaceutical development company that Dr. Caudill and Dr. Alfred Childers co-founded in 1991. Under their leadership Magellan grew to 600 people with 500 employees in RTP and 100 employees in San Diego. In 1998, Drs. Caudill and

Childers were named Entrepreneur of the Year for North and South Carolina by Ernst and Young, The Kauffman Foundation, USA Today, and NASDAQ and were Finalists for the 1998 National Entrepreneur of The Year. They received two awards from the North Carolina Council for Entrepreneurial Development (CED), the 2002 Entrepreneurial Excellence Award and the 2002 Deal of the Year Award. Dr. Caudill received his B.S. degree in Chemistry at the University of North Carolina at Chapel Hill with undergraduate research under the direction of Professor Royce Murray and in 1983 received his doctorate in Analytical Chemistry from Indiana. Upon graduation, he became a research scientist at Baxter-Travenol and, in 1987, joined the Glaxo Research Institute. He serves on the Advisory Board of Southern Capitol Ventures, serves on the Life Sciences Advisory Board of the Aurora Funds. He was a Steering Committee member of the $2.4 billion Carolina First Campaign and is chair of the Private Fundraising Steering Committee for the UNC-CH Physical Science Complex. He is an Adjunct Professor of Chemistry at the UNC-CH and a member of the UNC-CH Chemistry Department External Advisory Board. He is a member of the Advisory Working Group for the UNC-CH Entrepreneurship Minor. In 2008, he received the Distinguished Alumnus Award from UNC-CH. Professor Holden Thorp and he created and taught the first Scientific Ventures course for the UNC-CH Entrepreneurship Minor in spring of 2007, and he continues to co-teach this course with Professor Joe DeSimone. He and his wife, Suzi, and their three children reside in Durham.

THOMAS N. CHEWNING

Executive Vice President and CFO, Dominion (Retired) Richmond, Virginia

Thomas N. Chewning is retired executive vice president and chief financial officer of Dominion Resources.

He has held a variety of positions with Dominion since joining the company in 1987. During the preceding 10 years, Chewning served as chief executive officer of Air Van Lines Inc., a Seattle-based transportation company. He began his business career in 1969 as a commercial banker in North Carolina.

Chewning received his undergraduate degree in 1967 from the University of North Carolina at Chapel Hill. He received an MBA from the Wharton School of Finance in 1969.

He serves as a trustee of Virginia Union University. He is a member of the board of the Richmond chapter of the American Heart Association and served as co-chairman of its Save Lives Now! campaign. He also serves on the board of the Community Foundation and is chairman of the Board of U-turn Inc., a Christian ministry to young athletes. Chewning also serves as treasurer of the Virginia Early Childhood Foundation and chairman of the Regional Early Childhood Leadership Council.

He was co-chair of fund-raising for the Arthur Ashe Monument on Richmond’s historic Monument Avenue, for which Style magazine honored him as co-Richmonder of the Year, along with Paul DiPasquale, the monument’s sculptor. Institutional Investor magazine named Chewning CFO of the Year for the Utility Industry for 2005.

He served as chairman of the 2005 Richmond-area United Way campaign. He attends First Baptist Church, is an ordained deacon and is a member of the church’s Endowment Board.

He and his wife, Nancy, live in Richmond and have a son, a daughter and two grandsons.

ALFRED CHILDERS Co-founder of Magellan Laboratories, Inc. (Retired)

Cary, North Carolina

Dr. Childers is the former Worldwide President of Pharmaceutical Development for Cardinal Health which provides development services for the pharmaceutical industry. Dr. Childers led over 1600 employees in nine sites including Research Triangle Park (RTP), NC; San Diego, CA; Somerset, NJ; Philadelphia, PA; Manchester, UK; Swindon, UK; and Schorndorf, GER. In 1991, Dr. Childers, along with Lowry Caudill, co-founded Magellan Laboratories Incorporated and served as the President of Administration. Magellan Laboratories provided contract pharmaceutical product development and manufacturing services

including formulation development, clinical manufacturing, small-scale sterile and solid commercial manufacturing, clinical distribution, analytical development, inhalation

development, GMP synthesis, microbiology, drug discovery support, and biotechnology services. Drs. Childers and Caudill lead Magellan’s growth through both organic and acquisition growth. In April 2002, Cardinal Health acquired Magellan Laboratories for a reported $300 million. In 1998, Drs. Childers and Caudill were named Entrepreneur of the Year for the Carolinas by Ernst and Young, The Kauffman Foundation, USA Today, and NASDAQ and was a Finalist for the 1998 National Entrepreneur of The Year. They also received the 2002 Entrepreneurial Excellence Award and the 2002 Deal of the Year Award from the North Carolina Council for Entrepreneurial Development (CED). Prior to forming Magellan, Dr. Childers helped build the Pharmaceutical Development Division of Glaxo, Inc. Dr. Childers received his Ph.D. in Analytical Chemistry from Indiana University under the direction of Dr. Gary M. Hieftje and his B.S. in Chemistry from Furman University. He has authored over 50 articles and presentations in the areas of pharmaceutical product development and analytical sciences.

PHILLIP L. CLAY Chancellor, Massachusetts Institute of Technology

Cambridge, Massachusetts

Phil Clay is the chancellor of the Massachusetts Institute of Technology and professor of city planning. As chancellor, he has oversight responsibility for graduate and undergraduate education, student life and student services. He graduated from Carolina with a B.A. degree with honors in 1968 and earned his Ph.D. in 1975 from MIT. He received the University’s Distinguished Alumnus Award in 2002 and serves on the Academic Leadership Program National Advisory Board for the Institute for the Arts and Humanities at UNC. Dr. Clay, widely known for his work in U.S. housing policy, is president of the Board of Directors of the Community Builders, the nation’s largest nonprofit developer of affordable housing. He serves

on several boards and councils that address public policy and education in the United States and abroad. He currently serves as Secretary of the UNC Chapel Hill Board of Trustees. He and his wife have one daughter.

STACIE COCKRELL Author, Speaker

Austin, Texas

Stacie Harris Cockrell, co-author of Babyproofing Your Marriage, graduated from the University of North Carolina at Chapel Hill and went on to receive her MBA from the University of Texas. After graduate school, she was a finance and marketing professional at Dell Inc. and subsequently co-founded a high tech company in Austin, Texas. She currently resides in Austin with her husband, Ross, and their three children.

Endorsed by Brooke Shields and Dr. John Gray, Babyproofing Your Marriage has been published in 10 countries and has been featured in national and international publications including The Wall Street Journal, Parade, Parenting, Redbook, Fit Pregnancy and Best Life. Stacie has appeared on NBC's Today Show, Canada AM, iVillage Live, Fox News, Fox’s Mike and Juliet Morning Show, BabyTV.com, WebMD, and over 75 radio stations across the country including nationally syndicated Martha Stewart Living Radio and Satellite Sisters. Stacie is also an AOL Coach on Family and Kid issues and a post-baby relationship expert for eHarmony.com/Parenting. She is currently writing her second book, and just signed a working deal with the Co-Executive Producer of “Friends” to pitch Babyproofing Your Marriage to primetime and cable TV networks. Stacie Harris Cockrell graduated with a B.A. in Economics from the University of North Carolina at Chapel Hill in 1992.

JUDITH CONE Special Assistant to the Chancellor for Innovation & Entrepreneurship

UNC Chapel Hill

Judith Cone is Special Assistant to the Chancellor for Innovation & Entrepreneurship at the University of North Carolina at Chapel Hill. Her role is to assist the Chancellor, a serial entrepreneur and respected scientist, in formulating a strategic vision and plan for how UNC can create a culture of innovation that brings practical solutions to some of the biggest challenges facing the world today. Prior to joining the University of North Carolina at Chapel Hill, she was with the Ewing Marion Kauffman Foundation for 15 years serving in a number of roles. As vice president of emerging strategies for the Kauffman Foundation, she led efforts to explore

new program opportunities to advance entrepreneurship and innovation. Before that she was vice president of entrepreneurship and developed a number of the Foundation’s signature entrepreneurship initiatives for youth and adults, including one of its largest programs – the Kauffman Campuses Initiative, designed to transform the way entrepreneurship is taught on university campuses by making entrepreneurship education accessible to students and faculty across all fields of study. Cone joined the Foundation in 1993 and was responsible for the development of innovative entrepreneurial learning programs, including FastTrac and an award-winning Web portal for entrepreneurs. She also developed Kauffman’s knowledge management practice and played an instrumental role during a restructuring of the Foundation’s strategic focus. She continues to be affiliated with the Kauffman Foundation as a Senior Fellow. Cone co-founded and led for 14 years two management consulting firms serving Fortune 500 clients. Her first career was as a learning disabilities teacher working with disadvantaged children, where she experienced first-hand the pervasive and devastating effects of poverty on children and families. Cone writes and lectures nationally and internationally on entrepreneurship and innovation topics. She has a Bachelor of Arts degree from William Jewell College with areas of concentration in education and psychology, and a Master of Science degree with honors from the University of Kansas.

JOHN DENNISTON

Partner, Kleiner, Perkins, Caufield & Byers Menlo Park, California

John Denniston is a Partner with Kleiner Perkins Caufield & Byers. At KPCB, John has worked with a wide variety of portfolio companies, with a primary emphasis on the Greentech industry. John was a member of the KPCB Partner team that many years ago conceptualized and launched KPCB's Greentech investment initiative. Since then, KPCB has been an active investor in the Greentech field, having invested in start-up companies across a wide variety of sectors. John is an active participant in KPCB’s Greentech Innovation Network, a network of business, academic and policy leaders who

meet regularly to identify, and then pursue, the most important green technology and public policy innovations. He is actively involved in Greentech public policy issues, having testified before several Congressional committees. John serves on the Board of Advisors of the National Renewable Energy Labs. He is a frequent speaker at Greentech industry conferences. Prior to joining KPCB, John was a Managing Director and Head of Technology Investment Banking, Western U.S. at Salomon Smith Barney. He also served on the Investment Committees for both Salomon's venture capital direct investment fund and CitiGroup's venture capital fund-of-funds. Before that, he was a Partner at the law firm Brobeck, Phleger & Harrison, where he was the Head of the firm's Venture Capital Practice Group, co-head of its Information Technology Practice Group, and served on the Investment Committee for its venture capital fund.

ALSTON GARDNER Managing Director, Fulcrum Ventures LLC

New York, New York

Alston Gardner is a partner in Fulcrum Ventures, an Atlanta-based private equity firm. He was the founder and chief executive officer of OnTarget, Inc., a sales training and consulting firm serving technology companies such as IBM, Xerox, Hewlett Packard, Oracle, Cisco, Microsoft, Siemens, and Deutsche Telekom. Siebel Systems acquired OnTarget in 2000. He has been involved in a number of start-ups including Chatham Capital, Hatteras Venture Partners, Bandwidth.com, Biopheresis, Marketing Central, and Forte Software. Alston graduated from Carolina with a B.A. in 1977. He chaired the University’s International Studies Advisory Board until 2007 and helped lead the effort to build the FedEx Global Education Center.

He teaches in the MBA and BSBA programs at Kenan-Flagler and serves on the KFBS Board of Visitors. He currently serves on the UNC Board of Trustees. Alston lives in Chapel Hill and New York.

DENNIS GILLINGS Chairman, CEO, Quintiles Transnational Corporation

Durham, North Carolina

Dr. Dennis Gillings was born and educated in the United Kingdom. He began providing statistical consulting and data management services to pharmaceutical clients in 1974 during his tenure as Professor of Biostatistics at the University of North Carolina at Chapel Hill.. Quintiles arose from his consulting activities with the pharma industry and was incorporated in 1982 with 10 employees. He took Quintiles public on NASDAQ in 1994 and led its privatization in 2003. Today, Quintiles is the largest global provider of clinical trials and commercial marketing services to the pharma and biotechnology industry.

With nearly 30 years’ experience in drug development applications and theory, he has provided expert consultation to numerous companies and health organizations. He served for more than 15 years as a professor at the University of North Carolina at Chapel Hill and received the Honorary Degree of Doctor of Science in May 2001. Dr. Gillings was honored by the Queen as Commander of the Most Excellent Order of the British Empire in 2004 for services to the Pharmaceutical Industry. He was appointed Pro-Chancellor of Southampton University in 2006. In June 2008, Dr. Gillings was made Honorary Fellow of Queen Mary, University of London and was awarded an Honorary DSc at the University of Southampton. In September, 2008, the School of Public Health at UNC Chapel Hill was named the Gillings School of Global Public Health. The school’s mission is to advance the impact of economic and methodological research on health in both the developed and developing world.

JULIA SPRUNT GRUMBLES Vice President, Turner Broadcasting (Retired)

Chapel Hill, North Carolina

Julia Sprunt Grumbles has retired as corporate vice president of human resources, public relations and corporate marketing resources for Turner Broadcasting System, Inc. (TBS, Inc.). In this capacity, she oversaw all human resources, corporate philanthropy, community affairs, internal and external communications, advertising planning and placement, photo services, print production and presentation services. She was also responsible for entertainment, sports and news public relations, as well as overseeing the CNN Studio Tour and the Turner Store. Additionally, Grumbles served on the TBS, Inc. Executive Committee.

Earlier, Grumbles served as vice president of marketing for TBS Superstation. Her responsibilities included developing and overseeing the network’s marketing plan, and

coordinating public relations, advertising, promotion, research and cable sales activities related to the network’s strategic positioning. Before moving to TBS Superstation, Grumbles was senior vice president of Turner Network Sales (TNS), where she headed cable affiliate sales efforts for the western region and coordinated marketing and communications for the division. Earlier, she served as TNS western regional vice president and southeast regional sales manager and national accounts manager. Grumbles is the recipient of the National Cable Television Association’s Vanguard Award for Marketing, one of the cable industry’s most prestigious honors. She was named Woman of the Year by the Atlanta Chapter of Women in Cable and Television (WICT) and was given the same honor by the group’s national organization. She is past president of the International Women’s Forum of Georgia and served as an executive committee member of the board of trustees for the Atlanta Girls School, and of the Advisory Board for Trust for Public Land. She also served as a member of the board of directors for the Atlanta Botanical Gardens, Georgia Campaign for Adolescent Pregnancy Prevention (G-CAPP), and North Carolina Outward Bound. She currently serves on the boards of trustees for Highlands Biological Foundation, Atlanta Landmarks, Inc. (Atlanta’s Fox Theatre), University of North Carolina’s Institute of Arts and Humanities, UNC’s advisory board for Lineberger Cancer Center and UNC’s Health Care System. She also served on the national steering committee for the Carolina First campaign and was co-founder of UNC’s Carolina Women’s Leadership Council. Grumbles is a native of Memphis, TN, holds a bachelor’s degree from the University of North Carolina and is married to Bill Grumbles.

REGINALD LEE (REG) HARDY Co-founder and President, Concordia Pharmaceuticals

Fort Lauderdale, Florida

Reginald Hardy RPh., MBA, has successfully built an array of pharmaceutical and development companies and currently serves as the President of Concordia Pharmaceuticals, Inc. Mr Hardy was the Co-Founder and President of SANO Corporation that was acquired by Elan Corporation. Mr. Hardy served in various corporate capacities with Hoechst-Roussel Pharmaceuticals, Inc., Key Pharmaceuticals, Inc., IVAX Corporation and C/Max Capital Corporation. Reginald Hardy received his BS Pharmacy from UNC in 1981 and currently serves as a member of the Board of Visitors for the Eshelman School of Pharmacy.

DON HOLZWORTH

Chair, Futures Group, International Durham, North Carolina

Innovation Circle Member

Don Holzworth is the former Founder, Chairman, and Chief Executive Officer of Constella Group, a leading global provider of health consulting services dedicated to enhancing human health around the world. From 1991 to 2007, Holzworth guided Constella's revenue growth from less than $1 million to more than $200 million, increased the company's number of employees from 13 to 1,587, and the scope of the company’s operations to 61 countries. In August 2007, Holzworth completed the sale of Constella to SRA International, Inc. In September of 2008, Holzworth repurchased Futures Group, International, a former

division of Constella Group, and now serves as the Company's Chairman. In 2003 and again in 2007, the North Carolina Council for Entrepreneurial Development recognized Holzworth with its Entrepreneurial Excellence Award. In 2005, Ernst & Young named Holzworth as a Carolinas Entrepreneur of the Year® and he now serves as both a regional and national judge for this prestigious program. In 2002, Holzworth was a co-founder and served as the inaugural CEO of Expression Analysis, Inc., a start-up genomic services company spun out of Duke University Medical Center. He now serves as the company's Chairman of the Board. He also serves as Chairman of Casey Petraceuticals, a pet nutrition products company and is on the Board of the Campbell Alliance Group, a management consulting firm serving the pharmaceutical and biotech industries, and on the Advisory Board for Southern Capitol Ventures. His public health experience led to a 2008 appointment to the Presidential Advisory Council on HIV/AIDS and to the Board of the Accordia Global Health Foundation. He serves as Executive in Residence at the University of North Carolina Gillings School of Global Public Health, as a member of the School’s Advisory Council, Acceleration Advisory Committee, and is an Adjunct Professor of Health Policy and Management.

F. NEAL HUNTER Co-Founder, Executive Chair, Cree, Inc.

Durham, North Carolina

Neal Hunter earned his bachelor's degree in mechanical engineering from North Carolina State University in 1984. He is a co-founder and former President, CEO, and Chairman of Cree, Inc. Hunter held numerous roles at Cree from 1987-2005. During this time, the company's revenues grew to $400 million. In 2005, Hunter co-founded LED Lighting Fixtures, Inc. (LLF, Inc.) to accelerate the use of LEDs in general illumination applications. LLF has since set world records for LED fixture efficiency and CRI at warm white color temperatures. Funded by

employees, suppliers and distributors, LLF's goal is to bring economical high-volume LED lighting solutions to world markets. Hunter also develops residential neighborhoods using custom builders, giving him a unique perspective for applications of LED technology in homes. He resides in the RTP area of North Carolina and is an active supporter of UNC Hospitals, North Carolina State University, and the Food Bank of North Carolina.

BARBARA ROSSER HYDE Hyde Family Foundations

Memphis, Tennessee

Barbara Hyde is the president of J. R. Hyde III Family Foundation and director of the J.R. Hyde Sr. Foundation. The foundations support public education, civil rights and other worthy endeavors. She earned a B.A. in English and religion from Carolina in 1983. She is married to Pitt Hyde. As a Carolina student, Hyde was a Morehead Scholar and was inducted into the Order of the Old Well. She began her career in the University’s development office, serving as executive director of the Arts and Sciences Foundation from 1987 to 1992. On campus, she co-chaired the Women’s Leadership Council and served on the Carolina First Campaign Steering Committee. She serves on the

External Advisory Board of the Institute for the Arts and Humanities. She currently serves on the Board of Trustees at UNC Chapel Hill. In Memphis, she is an active board member of KIPP Academy, Shelby Farms Park Conservancy, the Women’s Foundation, and New Leaders for New Schools.

STUART JANNEY Board Chair, Bessemer Securities LLC

Butler, Maryland

Stuart S. Janney III is the Chairman of Bessemer Trust Company, Bessemer Trust Company, N.A., Bessemer Group, Inc., Bessemer Trust Company of Florida and Bessemer Securities Corporation since January 1995. In 1970 he graduated from the University of North Carolina at Chapel Hill with a B.A. and in 1973 he received his J.D. from the University of Maryland. From 1973-76 he held several positions in the Federal

government. He was a legislative assistant to U.S. Senator Charles Mathias, special assistant to the U.S. Secretary of State and later foreign policy assistant to U.S. Senator Howard Baker. In 1977 he joined Niles, Barton & Wilmer, a Baltimore law firm, where he was a partner. From 1986-94 he was a Managing Director of Alex Brown & Sons in charge of Asset Management. He was a Director of Brown Advisory and Trust Company and Alex Brown Holdings. His responsibilities included all investment advisory and investment partnerships.

He currently serves on the Boards of the Maryland Zoological Society, the New York Racing Association, the Keeneland Association, the Jockey Club, and the King Ranch, Inc. He is a trustee of The Johns Hopkins University and Chairman of its Applied Physics Lab. He is married with two children and resides in the Baltimore area.

KIMBERLY J. JENKINS Member, Board of Trustees, Duke University

Adjunct Professor Duke and UNC in Entrepreneurship Microsoft Senior Executive (Retired)

Chapel Hill, North Carolina

Kimberly Jenkins is a member of the faculty team that teaches the entrepreneurship bootcamp for UNC faculty, a frequent guest speaker at the Kenan-Flagler School of Business, and a teacher and mentor in the program for women in entrepreneurship run by fellow Innovation Circle member Julia Sprunt Grumbles. For the past four years, Kimberly has served as a part-time faculty member and mentor to students in the Masters in Engineering Management Program in the Duke University Pratt School of Engineering. Her teaching and speaking engagements focus

primarily on issues related to increasing the number and effectiveness of women and minorities in entrepreneurial careers. She also currently teaches courses in entrepreneurship and leadership to faculty and students at both Duke University and UNC, and has served as a member of the Duke University Board of Trustees since 2001. Dr. Jenkins, a graduate of Duke University (BS 1976, PhD 1980), is the former President of the Internet Policy Institute, an independent, nonprofit research and educational institute that examines global Internet policy issues. She was also the Founder, Chairman, and President of Highway 1, a nonprofit corporation focused on helping the federal government operate more effectively through the use of information technologies. During her career in management Kimberly Jenkins created Microsoft’s Education Division, ran market development at NeXT, and worked as a technical analyst for Control Data Corporation. She has also served as a consultant to companies such as Microsoft, Apple, Sun, Oracle, and Cisco.

BRENT JONES Managing Director, Northgate Capital

Danville, California

Brent has served as a Managing Director of Northgate since co-founding the firm in 2000. He has been an investor in Silicon Valley’s premier venture capital funds as well as an angel investor in several silicon valley start-ups including Data Domain, Nvidia, VA Linux, and Verisity.

Brent’s current activities include overseeing investments in Palo Alto Networks, Solexel, Kovio, Aoptix Technologies, Clearwell Systems, AdMob, and Meraki among others. Brent currently serves on the board of directors for Zazzle, a Kleiner Perkins-backed portfolio company. Brent also serves as an advisory board member to US Venture Partners. Active in the community, Brent is on the board of the Stanford Hospital Stroke Center, and also serves as a proud board member for the National Hockey League’s San Jose Sharks.

THOMAS P. KENNEDY Professor of Medicine; Director, Faculty Outreach Technology Commercialization

University of Utah Salt Lake City, Utah

Dr. Thomas Kennedy is a pulmonary and critical care physician and Professor of Medicine at the University of Utah. Dr. Kennedy received his M.D. degree from Vanderbilt University, where he was a Justin Potter Scholar and Founder’s Medalist, graduating first in his class. He completed an internal medicine residency and pulmonary/critical care fellowship at The Johns Hopkins Hospital and received his fellowship and M.P.H. in environmental medicine from The Bloomberg Johns Hopkins School of Hygiene and Public Health. He has served on the medical faculties of The Johns Hopkins Hospital, The Bloomberg Johns Hopkins School of Hygiene and Public Health, the University of Tennessee, Duke University, and the University of North Carolina. He has authored over 80 scientific publications, 21 U.S. patents (with foreign equivalents) and 5 Investigational New Drug applications to the U.S. FDA. Dr. Kennedy has founded four start-up biotechnology companies (Discovery Laboratories, ParinGenix, JSK Therapeutics, GlycoMira), for which he has raised over $40 million in seed investment. Dr. Kennedy currently serves the Technology Commercialization effort at the University of Utah as Director of Faculty Outreach, where he advises and assists other university faculty in pursuing technology commercialization and starting technology-based companies from the university environment.

JASON KILAR CEO, Hulu LLC

Los Angeles, California

Jason Kilar serves as the CEO of Hulu, an online video joint venture of News Corp and NBC Universal. Jason joined Hulu after nearly a decade of experience at Amazon.com where he served in a variety of key leadership roles. After writing the original business plan for Amazon's entry into the video and DVD businesses, he ultimately became Vice President and General Manager of Amazon's North American media businesses, which included the company's books, music, video, and DVD categories. He later served as Senior Vice President, Worldwide Application Software, where he led an organization of hundreds of world-class technologists and reported

directly to CEO Jeff Bezos. Jason began his career with The Walt Disney Company, where he worked for Disney Design & Development. He received his M.B.A. from Harvard Business School and graduated Phi Beta Kappa from the University of North Carolina, Chapel Hill, where he studied Business Administration and Journalism & Mass Communication.

RICHARD KRASNO Executive Director, William R. Kenan, Jr. Charitable Trust

Trustee, Kenan Institute of Private Enterprise Chapel Hill, North Carolina

Dr. Richard M. Krasno is currently the Executive Director of the William R. Kenan, Jr. Charitable Trust and President of the four affiliated William R. Kenan, Jr. Funds. Prior to joining the Trust in Chapel Hill, North Carolina, Dr. Krasno was President of the Monterey Institute of International Studies in Monterey, California. From 1981-1998 he served as President and Chief Executive Officer of the Institute of International Education in New York. He also served as U.S. Deputy Assistant Secretary of Education in Washington, D.C. and as a program officer of the Ford Foundation. Dr. Krasno holds a Ph.D. from Stanford University and honorary doctorates in law and humane letters from Sacred Heart University and the College of St. Rose. He

has held academic appointments at the University of Chicago, Stanford University, the University of Massachusetts, the Pontifical Catholic University of Rio de Janeiro, and the University of Santiago de Compostela, Spain, where he was a Senior Fulbright Professor.

Dr. Krasno has served as a director of the Whitman Corporation, the Ivax Corporation, and is currently a director of Ladenburg Thalmann Financial Services Company. He serves as Chairman of the Board of Directors of the University of North Carolina Health Care System, the governing body of the University of North Carolina Hospitals, and was awarded the William Richardson Davie award for extraordinary service by the University in 2009. He is the immediate past chairman of the regional Rhodes Scholarship selection committee in North Carolina and a trustee of the Eisenhower Fellowship Program. Dr. Krasno is a member of the Council on Foreign Relations and is listed in Who’s Who in America and Who’s Who in the World.

MYLA LAI-GOLDMAN Managing Partner Personalized Science, LLC

Chapel Hill, North Carolina

Dr. Lai-Goldman is the managing partner of Personalized Science, LLC, a consulting company whose mission is to assist its customers achieve successful adoption of innovative diagnostics with actionable results for patient’s unmet medical needs. Until her retirement on December 31, 2008, Myla P. Lai-Goldman, M.D. was Executive Vice President, Chief Medical Officer of Laboratory Corporation of America® Holdings (LabCorp®), where she managed LabCorp's National Office of Quality and Science, through which she was responsible for all quality, science and medical activities for LabCorp and its

subsidiaries. Dr. Lai-Goldman served as a member of LabCorp's Executive Committee from April 1998 until her retirement from the company. From 1998 until April 2008, Dr. Lai-Goldman also served as Chief Scientific Officer of the company, where she was responsible for R & D. Until 2006, she managed the operations of

the Company’s Center for Molecular Biology and Pathology in Research Triangle Park, NC; National Genetics Institute, Inc. in Los Angeles, CA; and ViroMed Laboratories, Inc. in Minneapolis, MN. Additionally, she held the position of Medical Director for the Center for Molecular Biology and Pathology from 1991 to 2005. Dr. Lai-Goldman joined the Company in 1990. Dr. Lai-Goldman earned an MD from the College of Physicians and Surgeons at Columbia University in New York, and completed postgraduate training in Internal Medicine at St Luke’s Hospital in New York, anatomic and clinical pathology at the UCLA Center for Health Sciences, and hematopathology at the University of North Carolina at Chapel Hill. She is board-certified in anatomic and clinical pathology, and is an Adjunct Professor of Pathology and Laboratory Medicine at UNC Chapel Hill.

RUBY LERNER President and Executive Director, Creative Capital Foundation

New York, New York

Ruby Lerner is the founding Executive Director and President of the Creative Capital Foundation, an innovative arts foundation modeled on venture capital concepts. Creative Capital was established in 1999 to provide support to individual artists in all disciplines and has funded 242 artists’ projects to date. Prior to Creative Capital, Ms. Lerner served as the Executive Director of the Association of Independent Film and Videomakers (AIVF) and as Publisher of the highly regarded Independent Film and Video Monthly. She has worked regionally in both the performing arts and independent media fields. She served as

the Executive Director of Alternate ROOTS, a coalition of Southeastern performing artists, and IMAGE Film/Video Center, both based in Atlanta. In the late 1970’s, she was the Audience Development Director at the Manhattan Theatre Club, one of New York’s foremost nonprofit theatres. A native of North Carolina, Ms. Lerner worked in the state’s visiting artist program following graduate work in theatre at the University of North Carolina-Chapel Hill. Her undergraduate degree is in comparative religion from Goucher College where she currently serves on the Committee of Visitors. During nearly 30 years in the arts, she has written and lectured extensively on arts issues, served on many boards, steering committees and grantmaking panels, and has consulted with hundreds of arts organizations on audience development and related areas of arts management. She is currently on the advisory committee for City at Peace and the annual Documentary Festival at the Museum of Radio and Television, on the steering committee for WNET’s REEL New York, and was recently elected to the board of the Aldrich Museum of Contemporary Art in Ridgefield, Connecticut.

DOUG MACKENZIE Founder, Partner, Radar;

Affiliated Partner at Kleiner, Perkins, Caufield & Byers Palo Alto, California

Doug Mackenzie joined Kleiner Perkins Caufield & Byers in 1989 and became a Partner in 1992. Since joining KPCB, Doug has focused his investment activities in the software sector, including enterprise applications, entertainment and educational software, and internet applications, tools and services. He currently serves on the Board of Directors of Safeway (public), as well as the following private companies: Devicescape Software, OnFiber, Scintera Networks, Trumba Corporation, and WeddingChannel (formerly Della.com). Previously, Doug had been either a Director of, or actively involved with KPCB's investments in: Pivotal Corporation (public), HomeGrocer.com (public, acquired by Webvan), Accept.com

(acquired by Amazon.com), Collabra Software (acquired by Netscape), Crystal Dynamics (acquired by Eidos), Diamond Lane Communications (acquired by Nokia), Edmark (public, acquired by IBM), E.piphany (public, acquired by SSA CRM) Marimba (public, acquired by BMC Software), On Technology (public), Preview Travel (public), Shiva (public) and Visio Corporation (public, acquired by Microsoft). In addition, he serves as co-Chairman of the Stanford Engineering Venture Fund, as a Board member of the Stanford Engineering Advisory Council, as an advisor to Pacific Community Ventures, as a Board member of Monterey Peninsula Foundation, as a Trustee of the U.S. Ski and Snowboard Team Foundation (USSTF), and he as a faculty member of the Stanford School of Engineering. Doug holds a bachelor's in Economics and a master's in Industrial Engineering from Stanford University, as well as an MBA from Harvard.

FRED McCOY Vice Chairman, Synecor LLC Chairman, TransEnterix, Inc.

Executive Chairman, InnerPulse, Inc. Chapel Hill, North Carolina

Fred McCoy is Vice Chairman of Synecor, LLC (www.synecor.com). Founded in 2000, Synecor has become a successful business accelerator focused on creating highly proprietary, disruptive technologies in the largest medical device and combination drug-device markets. In addition to his duties with Synecor, Mr. McCoy is active in business, academic, and civic pursuits. A native of Laurinburg, North Carolina, Mr. McCoy graduated with a degree of Bachelor of Science in Business Administration from the University of North Carolina at Chapel Hill in 1979. He graduated with a degree of Master of Management from the

Northwestern University J.L. Kellogg Graduate School of Management in 1981.

Mr. McCoy began his business career with Eli Lilly and Company in Indianapolis, Indiana. There he worked in a series of assignments of increasing responsibility in finance in the corporate, domestic, international, pharmaceutical, and agricultural businesses of the Company. During part of this early period, he also served as a pharmaceutical sales representative in Montgomery, Alabama. In 1988, Mr. McCoy became Vice President of Finance of Hybritech Incorporated, a Lilly subsidiary, in San Diego, California. In 1991, he became Chief Financial Officer of Cardiac Pacemakers, Inc., a Lilly subsidiary, in Saint Paul, Minnesota. Mr. McCoy entered general management in 1994 as General Manager, Northwest Operations, in Seattle, Washington. Later in 1994, Guidant Corporation was formed out of the medical technology enterprises of Lilly. In 1995, Mr. McCoy became Vice President of United States Operations – West. In 1997, he moved to Tokyo, Japan as President, Guidant Japan and Asia Pacific Operations. In May of 2000, Mr. McCoy became President, Guidant Cardiac Rhythm Management, in Saint Paul, Minnesota, where he served until his Guidant retirement in March 2006 pending the sale of the Company. Mr. McCoy is a member of the Boards of Directors of Synecor, LLC, TransEnterix, Inc., and InnerPulse, Inc., all located in the Research Triangle in North Carolina. He is a member of the Board of Directors of the North Carolina Advanced Medical Technologies Center of Innovation. He serves as a member of the Board of Trustees of St. Andrews Presbyterian College. He recently completed his term as a member of the Board of Visitors of the University of North Carolina at Chapel Hill. He is a member and past Chairman of the Kellogg Alumni Council of Northwestern University.

STEVE NELSON Managing Partner, Wakefield Group

Chapel Hill, North Carolina

Steve Nelson joined Wakefield Group in October 1999 and acts as its Managing Partner. He established the venture capital firm’s Research Triangle Park, NC office. Wakefield Group is a venture capital firm focused on providing growth capital to growing businesses. The firm focuses its investments in technology, healthcare, and business services. Wakefield generally invests $1 million to $5 million in each portfolio company with a focus on North Carolina and offices in Charlotte and the RTP.

Steve joined Wakefield after 19 years of executive and general management experience in technology, software and Internet-based businesses. During the last three years of his business career before starting at Wakefield, Steve was at Quokka Sports, a digital media company, in several executive capacities. Quokka raised over $140m in capital and successfully completed an IPO in July, 1999. He served as chief executive of a joint venture company between NBC Sports and Quokka Sports, NBC/Quokka Ventures. Prior to Quokka, Steve served as a Vice President with

Informix Software, based in Menlo Park, CA. His first business experience was 14-plus years at IBM, ultimately as Vice President and General Manager in San Francisco. Steve is a former member of the board of directors at Constella Group (successfully sold to SRA International - SRX), APEX Analytix (successfully sold to PNC), and Motricity (company raised over $450M, bought a division of InfoSpace, and moved to Seattle). He is currently a board member at PocketGear, Near-Time, rPath, FrontStream, RxMedic, Liquidia (where he also served as CEO), and BlueCross BlueShield of North Carolina, the largest health insurer in North Carolina. At BCBSNC, he is on the Business Investment Committee, chair of the Personnel & Compensation Committee, and a member of the Executive Committee. He is past Chairman and still an executive committee and board member of North Carolina’s Council for Entrepreneurial Development (CED), the largest entrepreneurial support organization in the country. He is also a Foundation Board member at the North Carolina School of Science & Math, and sits on the Board for the Triangle Community Foundation. Steve was a member of the Investment Advisory Committee for the State Treasurer of North Carolina for eight years (2001-2009), helping two elected treasurers oversee the state’s $67B investment portfolio. Recently, Governor Beverly Perdue announced the creation of the first ever North Carolina Innovation Council and asked Steve to be its co-chair with a goal to advise the Governor on: • coordinating public and private investments and policies to promote innovation; • moving innovative ideas from the lab to the marketplace more efficiently; and • strengthening collaboration among business, academia, state and local government. Steve received his B.S. degree in Business from Wake Forest University. He and his wife, Susan, have two daughters and reside in Chapel Hill.

TODD POPE President, CEO, TransEnterix, Inc.

Chapel Hill, North Carolina

As president and chief executive officer, Todd M. Pope sets the company’s strategic vision and oversees its organic growth. Pope has spent more than 20 years working in key leadership positions within the medical-device industry. Prior to joining TransEnterix, Pope served as worldwide president of Cordis, a multi-billion-dollar division within Johnson & Johnson’s medical-device sector. He previously held a number of leadership positions within Johnson & Johnson and Boston

Scientific. Pope has a special passion for managing emerging start-ups that have disruptive technologies with the potential to change the landscape of current standard of care.

JOHN POWELL Co-Founder, Managing Director Integral Capital Partners

Menlo Park, California

John Powell is a co-founder and Managing Director of Integral Capital Partners. Prior to forming Integral, John spent nine years at T. Rowe Price Associates in various research and portfolio management capacities. From March 1984 to March 1987, John was assistant portfolio manager of the T. Rowe Price Growth Stock Fund, a diversified growth fund whose assets grew to $1.6 billion from a base

of $900 million during that time. He was portfolio manager of the T. Rowe Price Science & Technology Fund from September 1987 to September 1988 and was portfolio manager of the T. Rowe Price Small Cap Value Fund from June 1988 to August 1991. John has a B.A. from the University of North Carolina at Chapel Hill and an M.B.A. from the Darden Graduate School of Business Administration of the University of Virginia. He serves as a Trustee of the Arts and Sciences Foundation of the University of North Carolina. John is a Chartered Financial Analyst.

JONATHAN RECKFORD CEO, Habitat for Humanity

Atlanta, Georgia

Jonathan Reckford is Chief Executive Officer of Habitat for Humanity. He took the helm at Habitat after a corporate career and his most recent position as executive pastor of the 4,300-member Christ Presbyterian Church of Edina, Minn., a suburb of Minneapolis. Before joining Christ Presbyterian, Reckford was president of stores for the Musicland division of Best Buy; senior vice president of corporate planning and communications for Circuit City; and director of strategic planning for Disney Design and Development.

Earlier, he had held positions at the Marriott Corp., Bain and Co. and Goldman, Sachs & Co.

THOMAS A. RIZK Chairman, CEO, TractManager

Saddle Brook, New Jersey Thomas A. Rizk serves as Chairman and Chief Executive Officer of TractManager. Prior to joining the Company, Mr. Rizk was chief executive officer and a director of Mack-Cali Realty Corporation (NYSE: CLI), a Real Estate Investment Trust (REIT) based in Cranford, New Jersey. In his tenure, Mr. Rizk built Cali into a leading super-regional REIT where he led the company through its highly successful initial public offering in 1994. He was responsible for establishing Cali’s position as one of the fastest-growing publicly traded REITs in the U.S. At the time of his retirement in April of 1999, Mack-Cali had a total capitalization of

more than $3 billion. Prior to joining Mack-Cali, Mr. Rizk was vice president and general counsel at Dubnoff & Koch, a New Jersey-based real estate development firm. As a practicing attorney, Mr. Rizk specialized in mergers and acquisitions, real estate and corporate law. Mr. Rizk also spent a number of years in the cable television industry, conducting mergers and acquisitions work during a period of transition and deregulation. Mr. Rizk received his B.A. degree in business administration from Rutgers University, his J.D. degree from Rutgers University School of Law, and his L.L.M. in taxation from the New York University School of Law.

CHRISTY SHAFFER CEO, Inspire Pharmaceuticals Chapel Hill, North Carolina

Dr. Christy Shaffer is a seasoned pharmaceutical executive and Ph.D. scientist with over 20 years of experience in the pharmaceutical/biotechnology industry. She has extensive experience in directing complex drug development processes for innovative products and raising substantial capital for a growing company. Dr. Shaffer was recruited by the founding scientists of Inspire as the first full-time employee in 1995, based on the purinergic receptor platform licensed from the University of North Carolina. She joined Inspire from Burroughs Wellcome where she had served as an International Project Leader, Medical Team Leader and Associate Director

of Respiratory and Critical Care Medicine. Dr. Shaffer was rapidly promoted after joining Inspire to VP of Development, Chief Operating Officer and, in 1998, President and Chief Executive Officer and Board member. Under Dr. Shaffer's tenure, Inspire secured over 10 corporate partnerships, including several collaborations with Allergan, a global leader in the field of ophthalmology. Inspire became a publicly traded company in 2000 and has completed multiple private equity and public offerings, raising over ~$400 million for Inspire. Dr. Shaffer was instrumental in attracting significant investments by Warburg Pincus in 2007 and 2009. Inspire expects to have revenues of $90m in 2009 and has over 200 employees, including a commercial sales force. Dr. Shaffer has received many notable awards including the 2009 Cystic Fibrosis most prestigious Breath of Life Award given for extraordinary commitment and support of the Foundation's mission, the Impact 24: Top Entrepreneurs of the Year, and Women Extraordinaire from Business Leader Magazine in 2008, YWCA Academy of Women 2007 Award in Science and Technology, the Charles & Colvard Women of Brilliant Achievement™ award, the Council for Entrepreneurial Development (CED) Award for Entrepreneurial Excellence in 2004 and Business Woman of the Year in NC 2003, 2004, by the Business Advisory Council in Washington, DC. Under Dr. Shaffer's leadership, Inspire was named one of The Scientist's Best Places to Work in Industry multiple times, one of Business North Carolina's Best Employers in North Carolina and received numerous Best Places to Work Awards for employers in Research Triangle Park. Inspire was also recognized by the American Heart Association as a Start! Fit-Friendly Company, and by Business Leader Magazine as one of the Healthiest Companies in the Triangle. Most recently, Inspire won the North Carolina Science and Technology Award for Breakthrough Research based on the Cystic Fibrosis Development Program.

Dr. Shaffer serves on numerous external boards, including the Biotechnology Industry Organization (BIO) Emerging Companies Section Governing Body, the Foundation Board of Directors of the North Carolina Museum of Art, the Kresge Science Advisory Board for Meredith College, and the NC School of Science and Math Foundation Board, the Advisory Board for the Morehead Planetarium and Science Center at the University of North Carolina, Board of Directors for Clinipace, a privately held clinical research software company in RTP, and the Cystic Fibrosis Foundation Carolinas Chapter Board, where she serves as the Chair. Dr. Shaffer also previously served as Chair of the Council for Entrepreneurial Development, which is the oldest and largest organization of its kind in the US, and was a past Board member of the North Carolina Biotechnology Center. She also served on the Business Advisory Board for a local venture capital fund, Hatteras BioCapital Fund LC in 2004 and was Co-Chair of the Triangle American Heart Association Walk in 2005. Dr. Shaffer received a B.S. in Biology/Chemistry and a Ph.D. in Pharmacology from the University of Tennessee. She completed two post-doctoral fellowships, one at the Chicago Medical School and the other at the University of North Carolina at Chapel Hill.

SALLIE SHUPING-RUSSELL Managing Director, BlackRock Alternative Advisors

Chapel Hill, North Carolina

Sallie Shuping-Russell is managing director of BAA, a unit of BlackRock. She was previously a principal at Quellos Private Capital Markets until it was acquired by BlackRock in October 2007. She graduated from Carolina with a B.A. in English and political science in 1977 and earned an M.B.A. from Columbia University in 1983. Her University service has included the University Board of Visitors, the Board of Advisors of the School of Public Health, a Trustee of the Endowment Fund, a director of the UNC Foundation and the Board of Directors of the Foundation Investment Fund, Inc. She is a former

member of the Board of Directors of the UNC Health Care System. Shuping-Russell was a general partner with Intersouth Partners, an early stage venture capital firm, and a founding member and vice president of the Duke Management Company, where she was responsible for the private investment portfolio and an assistant vice president of Duke University. She also was vice president at McMillion/Eubanks Capital Management in Greensboro, and was a consultant with Cambridge Associates in Boston prior to returning to North Carolina. She currently serves on the Board of Trustees at UNC Chapel Hill. She formerly served on the Boards of Commonfund Capital, the North Carolina Biotechnology Center, the Council for Entrepreneurial Development Board, and as a trustee of St. Mary’s School.

RICHARD STACK

Director, Founder, President, Synecor LLC Chapel Hill, North Carolina

Richard Stack, M.D., is a co-founder of Synergy Life Science Partners. Additionally, Richard is President of Synecor, LLC, a business generator and financial incubator of new medical device companies. In the past six years, Richard has co-founded and invested in five major medical device companies, including Synecor. Richard chairs the scientific advisory board, leads the pre-clinical testing services provided and is the interim President of each Synecor spinout company.

Richard is recognized as an international thought leader in the medical technology field. He has authored over 360 manuscripts, book chapters and scientific abstracts. He has been a principal and co-principal investigator of three NIH grants and received numerous research awards during his career including the International Award for Best Interventional Cardiology Experimental Research (1995, Netherlands). Richard has invented and/or invested in numerous technologies that have become widely adopted by physicians the world over. He has over 70 worldwide patents issued or pending on a wide variety of medical devices. Richard is a co-founder of BaroSense, InnerPulse and TransEnterix. Additionally, Richard serves on the Board of Directors and is the Scientific Advisory Board Chairman of BaroSense. Richard is Professor Emeritus of Medicine in Cardiology at Duke University in Durham, North Carolina, where he spent his entire academic medical career, since 1981, as Founder and Director of Duke Interventional Cardiology. Richard retired early from his academic career to join the investment community with the formation of Synecor, LLC in 2000

WILLIAM (BILL) N. STARLING

CEO, Synecor, LLC Managing Director, Synergy Life Science Partners

Portola Valley, California

William N. Starling is General Partner of Synergy Life Science Partners, LP (www.synergylsp.com) and Chief Executive Officer of Synecor, LLC, (www.synecor.com) a business generator of new Life Science companies based in Research Triangle Park (RTP), North Carolina, Santa Rosa, California, and Portola Valley, California. Synecor (www.synecor.com) has significant academic, scientific, physician, venture capital, corporate, and investment banking partnerships and is focusing its efforts on the identification and development of proprietary, disruptive technologies with extraordinary market potential in the life

sciences field. As CEO of Synecor, Mr. Starling is a cofounder of BaroSense, Inc., Bioerodible Vascular Solutions, Inc., (acquired by Guidant/Abbott in April 2004), InnerPulse, Inc., TransEnterix, Inc., and Interventional Autonomics Corporation, the initial five companies founded and incubated by Synecor. Mr. Starling currently serves as Chairman of the Board of InnerPulse Inc., a RTP, NC - based cardiac rhythm management company, Chairman of the Board of Interventional Autonomics Corporation, and as a board member of TransEnterix, Inc., a RTP, NC - based less invasive GI Surgery company. William N. Starling received his BSBA degree from the University of North Carolina at Chapel Hill and his MBA degree from the University of Southern California. He began his 32 year career in the medical technology device industry at American Edwards Laboratories (Edwards LifeSciences - NYSE:EW). He was subsequently part of the founding management team and Director of Marketing for Advanced Cardiovascular Systems, Inc. (acquired by Guidant/Abbott), and was a cofounder, Vice President and Board member of Ventritex, Inc. (acquired by St. Jude Medical). In 1992, Mr. Starling was a cofounder and

Chairman of the Board of Directors and President/CEO of Cardiac Pathways Corporation (acquired by Boston Scientific Corporation in 2001). Mr. Starling serves on the Lineberger Comprehensive Cancer Center Board of Visitors at the University of North Carolina at Chapel Hill. He also serves as Chairman of the Board of Visitors at the Kenan-Flagler Business School at UNC, where he frequently lectures to both undergraduate and graduate students on entrepreneurism.

MATTHEW SZULIK CEO, Red Hat (Retired) Raleigh, North Carolina

Matthew Szulik has been leading early-stage technology companies, such as Interleaf, MapInfo, and Red Hat, into global, publicly traded firms for more than 20 years. In 1998, Szulik and Red Hat founder Bob Young developed a shared vision that the collaborative approach of open source and a great brand could redistribute the economics of the technology industry from vendor to customer. Following successful public offerings in 1999 and 2000, Red Hat has developed global partnerships with Oracle, IBM, Dell, Intel, and HP

to deliver technology based on open source technology. Today, Red Hat is the leading provider of Linux and open source technology to the enterprise and is positioned to be the defining technology company of the 21st century. Szulik is passionate about improving the educational opportunities for students worldwide through open source, and he is a spokesperson to industry, government, and education leaders on open source computing. He is the Chairman of the Science and Technology Board for State of North Carolina's Economic Development Board, and is past Chairman and an Executive Director of the North Carolina Electronics and Information Technologies Association. Szulik was recently recognized by CIO Magazine with its 20/20 Vision Award.

TOM UHLMAN Founder, Managing Partner New Venture Partners, LLC

Madison, New Jersey

Tom Uhlman is the co-Founder and a Managing Partner of New Venture Partners, a global venture capital firm dedicated to corporate technology spin-outs which has over $700 million under management. Previously, Tom served as President of Lucent Technologies' New Ventures Group. Between 1997 and the present, Tom and his colleagues have created over 60 new technology businesses. Tom has also held senior executive positions at Lucent Technologies and AT&T. At Lucent, he was Senior Vice President, Corporate Strategy, Business Development

and Public Affairs responsible for strategy, mergers and acquisitions, planning and government affairs activities. Tom was Vice President of Corporate Development in charge

of merger, acquisition and divestiture activity at AT&T. From 1985 to 1995, Tom was Director of Corporate Development at Hewlett-Packard, leading worldwide equity investment, strategic alliance, and strategic planning efforts. Tom also worked in both the government and academic arenas. He managed the President's Commission on Industrial Competitiveness on behalf of the Chief Executive of Hewlett-Packard, who chaired this White House Commission. In 1981 and 1982, he was Director of Productivity Improvement at the U.S. Department of Education. Previously, he was an Assistant and then an Associate Professor of Political Science at the University of Missouri-St. Louis. At the university, Tom was the author of a book, a dozen journal articles, and received an award for the best U.S. doctoral dissertation in the field of law. Tom currently sits on the boards of several portfolio companies and non-profit, charitable organizations. Previously, he co-chaired the New Jersey Governor's High Technology Task Force with the President of Princeton University. In 2002, he was the recipient of the New Jersey Technology Council's "Financier of the Year" award. Tom holds a Ph.D. in Political Science from UNC as well as a Masters degree from Stanford University's School of Business. He received his BA in Political Science from the University of Rochester.

EDWARD VICK CEO, Chairman, Young and Rubicam (Retired)

Old Greenwich, Connecticut

Ed Vick spent over 30 years in the marketing communications business, nearly half of that in Chairman, CEO or COO positions. Most recently, he held the posts of Chairman of Young & Rubicam Advertising and its parent, Young & Rubicam Inc., an S&P 500 company until its acquisition by British holding company WPP. He retired in 2001 and is currently engaged in pro-bono activities, including his role as Chairman of Iraq and Afghanistan Veterans of America (iava.org). IAVA is the nation’s first and largest not-for-profit organization dedicated to improving the lives our troops, veterans and their families.

A native of Philadelphia, Ed holds a Bachelor’s degree in Journalism from the University of North Carolina at Chapel Hill and has remained involved with JOMC over the years. He is currently Chairman of the school’s Board of Advisors. He has initiated the Edward Vick Award for Innovation in Teaching, a $10,000 prize given each year to the JOMC professor who has demonstrated the most innovation in teaching. Ed has served on a number of boards during his career, including The American Foundation for Aids Research, the United Negro College Fund, The Advertising Education Foundation, The American Association of Advertising Agencies, Blue Martini Software, Discovery’s The Military Channel, Iraq and Afghanistan Veterans of America and Young & Rubicam Inc. He is a member of the Council on Foreign Relations, The St. Andrews Society, The Union League Club, and Vietnam Veterans of America. A Naval officer prior to commencing his business career, Ed served with the elite River Patrol Force, leading over 100 combat missions throughout Vietnam’s Mekong Delta and along the Cambodian border at the height of the war. He holds two Bronze Star Medals with Combat “V".

Ed has three kids and lived many years in New York City. He now lives on Long Island Sound in Old Greenwich, Connecticut, about an hour northeast of New York City.

KAY WAGONER Co-founder, President, CEO, Director Icagen, Inc.

Chapel Hill, North Carolina

Dr. Wagoner is a co-founder of Icagen, Inc. and has served as our president and a director since our inception and as chief executive officer since September 1996. Prior to founding Icagen, Dr. Wagoner served in research management positions at Glaxo Inc. where she initiated and led Glaxo’s U.S. ion channel discovery efforts in central nervous system, cardiovascular and metabolic disease. In 2001, Dr. Wagoner received the distinguished alumna award for science and business from the University of North Carolina, Chapel Hill. Dr. Wagoner also serves or has served on a variety of boards of directors, including the University of North Carolina’s Graduate School Advisory Board and the Governing Body of the Biotechnology Industry

Organization’s (BIO) Emerging Companies Section. In 2004, Dr. Wagoner was awarded the Entrepreneurial Excellence Award by the Research Triangle-based Council for Entrepreneurial Development, the largest entrepreneurial support organization in the United States, and the Ernst & Young Entrepreneur of the Year Regional Award for Life Sciences and Healthcare. In 2007, Dr. Wagoner received the Women in Bio outstanding achievement award for excellence in capital raising. Dr. Wagoner received her Ph.D. in physiology from the University of North Carolina at Chapel Hill.

DEBBIE WRIGHT Chief Counsel Global IP – Open Innovation and Supply Chain, Kraft Foods

Chicago, Illinois

Debbie K. Wright is Chief Counsel – Global IP Open Innovations & Supply Chain for Kraft Foods, a Fortune 50 Chicago North Suburban Corporation. She has primary responsibility for all Intellectual Property issues for the Open Innovation and Supply Chain groups. Previously she was Chief Counsel Global Patents for Kraft. She is also Assistant Secretary for Kraft Foods Global Brands, Inc. Ms. Wright lectures frequently on a variety of intellectual property topics. Prior to joining Kraft, she worked as a patent attorney for the former Upjohn Company in Kalamazoo, MI.

Ms. Wright is a North Carolina native and started her legal career with the North Carolina Department of Justice in Raleigh, North Carolina. She received her B.S. Degree in Biology from Western Carolina University where she was the Dobson Scholar in Biology. She attended the Bowman Gray School of Medicine and received her law degree from the University of North Carolina in Chapel Hill, North Carolina. She is Past-President of the Intellectual Property Lawyers Association of Chicago (IPLAC), Secretary to the IPLAC Scholarship Foundation and a member of the National Bar Association, American Bar Association, and the American Intellectual Property Law Association, Trustee for American

Intellectual Property Law Education Foundation. She is a Master of Bench of The Richard Linn American Inn of Court. She serves on the boards of the Ada S. McKinley Community Services and Metropolitan Family Services. She is also a member of The Links Incorporated. Ms. Wright is admitted to practice before the State bars of North Carolina, Illinois, Michigan; the North Carolina U.S. District Court for the Eastern and Middle Districts as well as the United States Patent and Trademark Office.